For KRAS analysis, this was concordant across all technologies, however the BRAF mutation at codon 600 was called in 1/3 colorectal carcinoma samples though at a low coverage equal to 4.38% and only by 1/4 analysis (IonTorrent, Table 2). Here, KRAS is linked to colorectal carcinoma.